T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
21 hedge funds and large institutions have $4.24M invested in T2 Biosystems, Inc in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 21 → 21 (0)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
66% less capital invested
Capital invested by funds: $12.6M → $4.24M (-$8.31M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$295K |
| 2 |
Millennium Management
New York
|
+$149K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.5K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.35K |
| 5 |
Barclays
London,
United Kingdom
|
+$383 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$994K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$150K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$44.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$20K |
| 5 |
BlackRock
New York
|
-$5.58K |
TTOO Hedge Fund Activity: Q3 2024 in Review
21 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2024, worth a combined $4.24M — down 66% from $12.6M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TTOO positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $295K. The largest seller was Armistice Capital, cutting an estimated $994K.
- 21 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $4.24M of T2 Biosystems, Inc stock for Q3 2024, down 66% quarter-over-quarter.
- 2 funds opened new T2 Biosystems, Inc positions in Q3 2024 and 1 closed out, a net change of +1 holder.
- The largest T2 Biosystems, Inc buyer in Q3 2024 was Vanguard Group, an estimated $295K added.
- The largest T2 Biosystems, Inc seller in Q3 2024 was Armistice Capital, an estimated $994K sold.
Based on aggregated 13F filings for Q3 2024.